Illustration of a row of domino pieces.

Migraine - Management


The domino effect: What happens when migraine treatments block the CGRP pathway?

An ever-growing body of evidence suggests that calcitonin gene-related peptide (CGRP) plays a crucial role in the pathophysiology of migraine. 1 Indeed, CGRP is released during acute migraine attacks2 and the intravenous infusion of CGRP in patients with migraine act

Login to register to read this article

If you do not have a Log in, please register to be part of a big community, experience premium content and stay informed about exclusive professional events.

Log In

Not registered yet? Register now